Skip to main content
. 2017 Feb 21;15(4):1973–1980. doi: 10.3892/mmr.2017.6226

Table VI.

DAI and HPS scores of each group.

Group DAI HPS
Control 0 0
Model 8.05±1.97a 14.55±0.86a
Golden bifid 4.73±1.04a,b 9.97±1.58a,b
TLR4mAb 5.08±2.18a,b 10.11±2.11a,b
a

P<0.05 vs. the control

b

P<0.05 vs. the model group. TLR4mAb, Toll-like receptor 4 monoclonal antibody; DAI, disease activity index; HPS, histopathological scoring.